Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 483 results for "sun pharma"

Buy Sun Pharma Adv, Manpasand Beverage, IGL: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma Advanced Research Company, Manpasand Beverage and Indraprastha Gas. Money Control, 3 hours ago

311 images for sun pharma

Money Today, 1 week ago
Money Control, 1 week ago
One India, 1 week ago
Money Control, 1 week ago
Moneycontrol.com, 3 weeks ago
Money Today, 3 days ago
Sify, 1 week ago
Reuters, 1 week ago
Deccan Chronicle, 1 month ago
Sify, 1 week ago
Money Today

Nifty reclaims 8900, Sensex firm in early trade; Idea slips 3%

Cipla, ONGC, Tata Motors, GAIL, NTPC, Tech Mahindra, Bharti Infratel, Aurobindo Pharma and Grasim were early gainers while ITC, Bajaj Auto, Infosys, Sun Pharma, Reliance Industries, BPCL and Hindalco were losers.
 Money Control6 hours ago Sensex, Nifty open flat with positive bias; Infosys gains  Money Control1 week ago Nifty ends at 8822, Sensex rises 167 pts; HDFC Bank gains 3.6%  Money Control1 week ago Sensex snaps 2-day losses, Nifty ends above 8750; pharma shines  Money Control1 week ago
[x]  

Top pharma cos overcharging, NPPA lists 634 drugs for breaching price cap

NPPA has named Sun Pharma, Cipla, Lupin, Abbott, Biocon, Wockhardt, others
 Business Standard6 hours ago

Need to keep pace with industry on tech upgradation: Sun Pharma

The 2-day Indian Pharma Alliance Conference concluded on Friday and speaking at the conference, Founder and MD of Sun Pharma, Dilip Shanghvi as well as Pankaj Patel of Zydus Cadila say that efforts are underway to meet global quality standards in both ...
 Money Control17 hours ago
Reuters

Sun Pharma Q3 net dips 5% to Rs 1,471 cr on slower sales in US

Sun also said sales in its emerging markets rose 14% and those in the rest of the world were up 33%
 Business Standard1 week ago Sun Pharma Q3 profit dips 5% to Rs 1,472 cr  Business Standard1 week ago Sun Pharma reports surprise drop in profits  Business Standard1 week ago Sun Pharma's profits drop as U.S. sales hit by pricing, supply issues  Reuters1 week ago
[x]  
DNA

Doctors may soon have to kiss goodbye to lavish freebies from pharma companies

Doctors may soon have to bid farewell to the lavish gifts that pharmaceutical companies and representatives bestow upon them as the government is planning to set a Rs 1,000 cap. According to a report in The Times of India , the Department of Pharmaceuticals ...
 DNA2 days ago

SPARC gets income tax demand notice for Rs 32.87 cr

Sun Pharma Advanced Research Company (SPARC) today said it has received a demand notice from income tax authorities for a sum of Rs 32.87 crore. The company is contesting the demand, which is for the assessment year 2013-14, SPARC said in a regulatory filing.
 Business Standard3 days ago

Buy Bharat Financial, Sun Pharma; sell Bharti Infratel: Thakkar

Mitessh Thakkar of miteshthacker.com is of the view that one can buy Bharat Financial Inclusion and Sun Pharmaceutical Industries and sell Bharti Infratel.
 Money Control1 week ago Buy Reliance Infrastructure, Sun Pharma: Mitessh Thakkar  Money Control2 weeks ago Buy Sun Pharma; sell MRF, Tata Motors DVR: Mitessh Thakkar  Money Control3 weeks ago Buy Shree Renuka Sugars, Sun Pharma: Mitessh Thakkar  Money Control3 weeks ago
Sify

Sensex surges over 150 points; Sun Pharma, Infosys up

Indian markets bounced back on Thursday snapping earlier losses. At 02.00 p.m, the Sensex was trading up 168.09 points or 0.60% at 28,323.65 with 22 components gaining. Meanwhile, the Nifty was trading higher by 51.20 points or 0.59% at 8,775.90 with 40 ...
 Myiris1 week ago Sensex, Nifty trade flat; Sun Pharma, Tata Motors top gainers  Myiris1 week ago Indian shares down; Tata Motors, Sun Pharma drag  Sify1 week ago Sensex down over 150 points; Tata Motors, Sun Pharma drag  Myiris1 week ago
[x]  

Buy Sun Pharma; target of Rs 850: HDFC Securities

HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 850 in its research report dated February 15, 2017.
 Money Control5 days ago Buy Sun Pharma; target of Rs 810: Centrum  Money Control4 days ago Buy Sun Pharma; target of Rs 875: Religare  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less